These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34094337)

  • 41. Surface interaction between glycosaminoglycans and calcium oxalate.
    Angell AH; Resnick MI
    J Urol; 1989 May; 141(5):1255-8. PubMed ID: 2709520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemistry and Function of Glycosaminoglycans in the Nervous System.
    Schwartz NB; Domowicz MS
    Adv Neurobiol; 2023; 29():117-162. PubMed ID: 36255674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation of lipid-derivatized glycosaminoglycans to probe a regulatory function of the carbohydrate moieties of proteoglycans in cell-matrix interaction.
    Sugiura N; Sakurai K; Hori Y; Karasawa K; Suzuki S; Kimata K
    J Biol Chem; 1993 Jul; 268(21):15779-87. PubMed ID: 8340404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The regional contribution of glycosaminoglycans to temporomandibular joint disc compressive properties.
    Willard VP; Kalpakci KN; Reimer AJ; Athanasiou KA
    J Biomech Eng; 2012 Jan; 134(1):011011. PubMed ID: 22482666
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of a Bacteroides species from human intestine that degrades glycosaminoglycans.
    Ahn MY; Shin KH; Kim DH; Jung EA; Toida T; Linhardt RJ; Kim YS
    Can J Microbiol; 1998 May; 44(5):423-9. PubMed ID: 9699297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo and in vitro glycosaminoglycans from human dental pulp.
    Mangkornkarn C; Steiner JC
    J Endod; 1992 Jul; 18(7):327-31. PubMed ID: 1402594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease.
    Souza-Fernandes AB; Pelosi P; Rocco PR
    Crit Care; 2006; 10(6):237. PubMed ID: 17118216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exogenous glycosaminoglycans stimulate hyaluronic acid synthesis by cultured human trabecular-meshwork cells.
    Binninger EA; Schachtschabel DO; Rohen JW
    Exp Eye Res; 1987 Jul; 45(1):169-77. PubMed ID: 2958306
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid Fabrication of Biocomposites by Encapsulating Enzymes into Zn-MOF-74 via a Mild Water-Based Approach.
    Hsu PH; Chang CC; Wang TH; Lam PK; Wei MY; Chen CT; Chen CY; Chou LY; Shieh FK
    ACS Appl Mater Interfaces; 2021 Nov; 13(44):52014-52022. PubMed ID: 34232015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The glycosaminoglycan interactome 2.0.
    Vallet SD; Berthollier C; Ricard-Blum S
    Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1271-C1278. PubMed ID: 35544698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exogenous glycosaminoglycans (GAG) differentially modulate GAG synthesis by anchorage-independent cultures of the outer cells from neonatal rat calvaria in the absence and presence of TGF-beta.
    Anastassiades TP; Chopra RK; Wood A
    Mol Cell Biochem; 1996 May; 158(1):25-32. PubMed ID: 8791281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of Nitric Oxide-Releasing Glycosaminoglycans in Wound Healing.
    Maloney SE; Broberg CA; Grayton QE; Picciotti SL; Hall HR; Wallet SM; Maile R; Schoenfisch MH
    ACS Biomater Sci Eng; 2022 Jun; 8(6):2537-2552. PubMed ID: 35580341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acidic glycosaminoglycans in human atherosclerotic cerebral arterial tissues.
    Murata K; Yokoyama Y
    Atherosclerosis; 1989 Jul; 78(1):69-79. PubMed ID: 2502994
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects.
    Pieper JS; Hafmans T; Veerkamp JH; van Kuppevelt TH
    Biomaterials; 2000 Mar; 21(6):581-93. PubMed ID: 10701459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
    Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
    Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The structure of glycosaminoglycans and their interactions with proteins.
    Gandhi NS; Mancera RL
    Chem Biol Drug Des; 2008 Dec; 72(6):455-82. PubMed ID: 19090915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glycosaminoglycan Neutralization in Coagulation Control.
    Sobczak AIS; Pitt SJ; Stewart AJ
    Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1258-1270. PubMed ID: 29674476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of chondroitin 6-sulfate and hyaluronan from failed porcine bioprosthetic valves.
    Grande-Allen KJ; Mako WJ; Calabro A; Shi Y; Ratliff NB; Vesely I
    J Biomed Mater Res A; 2003 May; 65(2):251-9. PubMed ID: 12734820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic applications of glycosaminoglycans.
    Volpi N
    Curr Med Chem; 2006; 13(15):1799-810. PubMed ID: 16787222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A versatile stimulus-responsive metal-organic framework for size/morphology tunable hollow mesoporous silica and pH-triggered drug delivery.
    Zou Z; Li S; He D; He X; Wang K; Li L; Yang X; Li H
    J Mater Chem B; 2017 Mar; 5(11):2126-2132. PubMed ID: 32263685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.